EP3757107
4-OXÓ-3,4-DÍHÝDRÓÞÍENÓ[3,4-D]PÝRIDASÍN EFNASAMBÖND SEM ALDÓSAREDÚKTASAHEMLAR OG AÐFERÐIR VIÐ NOTKUN ÞEIRRA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.6.2017EP published:
25.10.2023EP application number:
20188323.8
EP translation filed:
8.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
20.6.2037Expiry date:
20.6.2026Next due date:
30.6.2026
Title in English:
4-OXO-3,4-DIHYDROTHIENO[3,4-D]PYRIDAZINE COMPOUNDS AS ALDOSE REDUCTASE INHIBITORS AND METHODS OF USE THEREOFLanguage of the patent:
English
Timeline
Today
21.6.2017EP application
25.10.2023EP Publication
8.12.2023Translation submitted
15.1.2024Registration published
20.6.2026Expires
Owner
Name:
The Trustees of Columbia University in the City of New YorkAddress:
412 Low Memorial Library 535 West 116th Street, New York, NY 10027, US
Inventor
Name:
WASMUTH, AndrewAddress:
Brooklyn, NY 11201, US
Name:
LANDRY, Donald W.Address:
New York, NY 10027, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201662352784 PDate:
21.6.2016Country:
US
Classification
Categories:
C07D 495/04, A61K 31/5025, A61P 9/10, A61P 17/00, A61P 13/12, A61Q 19/08
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 31.5.2024
Expires: 20.6.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.7.2025
Expires: 20.6.2026
Payer: Árnason Faktor ehf.